Literature DB >> 20067407

Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

Hatim Hemeda1, Mark Jakob, Anna-Kristin Ludwig, Bernd Giebel, Stephan Lang, Sven Brandau.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent progenitor cells with the capacity to differentiate into different tissue cell types such as chondrocytes, osteocytes, and adipocytes. In addition, they can home to damaged, in-flamed, and malignant tissues and display immunomodulatory properties. Since tissue-derived factors might modulate these properties, we decided to explore the impact of prototypic tissue-derived inflammatory cytokines such as TNF-alpha and IFN-gamma on immunomodulatory MSCs functions. To this end, we used primary bone marrow and cord blood-derived MSCs as well as an immortalized MSC line (V54/2) as model systems. We demonstrate that under unstimulated conditions, V54/2 cells constitutively express low levels of indoleamine 2,3-dioxygenase (IDO), exert an immunosuppressive effect on activated T-lymphocyte proliferation, secrete a distinct set of cytokines, and express a wide range of chemokine receptors. Upon stimulation, the proinflammatory cytokines IFN-gamma and TNF-alpha did not inhibit suppression of T-cell proliferation, although IDO expression was up-regulated by IFN-gamma. In contrast, TNF-alpha but not IFN-gamma amplified the cytokine production of V54/2 and primary MSCs. Interestingly, IFN-gamma was superior to TNF-alpha in up-regulating expression of chemokine receptors and migration of the V54/2 cell line, while TNF-alpha was the predominant regulator of migration in primary MSCs. Altogether, our data show that properties of MSCs depend on local environmental factors. In particular, we have shown that IFN-gamma and TNF-alpha differentially regulate cytokine expression and migration of MSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067407     DOI: 10.1089/scd.2009.0365

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  71 in total

1.  Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells.

Authors:  M J Crop; C C Baan; S S Korevaar; J N M Ijzermans; M Pescatori; A P Stubbs; W F J van Ijcken; M H Dahlke; E Eggenhofer; W Weimar; M J Hoogduijn
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

2.  Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials.

Authors:  Catarina R Almeida; Daniela P Vasconcelos; Raquel M Gonçalves; Mário A Barbosa
Journal:  J R Soc Interface       Date:  2011-07-13       Impact factor: 4.118

3.  Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue.

Authors:  Erja Kerkelä; Tanja Hakkarainen; Tuomas Mäkelä; Mari Raki; Oleg Kambur; Lotta Kilpinen; Janne Nikkilä; Siri Lehtonen; Ilja Ritamo; Roni Pernu; Mika Pietilä; Reijo Takalo; Tatu Juvonen; Kim Bergström; Eija Kalso; Leena Valmu; Saara Laitinen; Petri Lehenkari; Johanna Nystedt
Journal:  Stem Cells Transl Med       Date:  2013-06-03       Impact factor: 6.940

Review 4.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

5.  Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis.

Authors:  Yueqiu Chen; Yuxian Song; Huishuang Miao; Yujun Xu; Mingming Lv; Tingting Wang; Yayi Hou
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

6.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.

Authors:  Daan R M G Ophelders; Tim G A M Wolfs; Reint K Jellema; Alex Zwanenburg; Peter Andriessen; Tammo Delhaas; Anna-Kristin Ludwig; Stefan Radtke; Vera Peters; Leon Janssen; Bernd Giebel; Boris W Kramer
Journal:  Stem Cells Transl Med       Date:  2016-05-09       Impact factor: 6.940

Review 7.  Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms.

Authors:  Li Li; Jianxin Jiang
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

8.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

9.  Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Authors:  Qiushi Wang; Qiaoni Yang; Zhe Wang; Haixia Tong; Liangyan Ma; Yi Zhang; Fengping Shan; Yiming Meng; Zhengwei Yuan
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 10.  Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.